Arcus Biosciences (RCUS) EPS (Basic) (2017 - 2026)
Arcus Biosciences (RCUS) posted quarterly EPS (Basic) of -$1.02 for Q1 2026, up 10.32% year-over-year from -$0.93 in Q1 2025, and down 3.42% quarter-over-quarter from -$0.99 in Q4 2025.
Arcus Biosciences (RCUS) EPS (Basic) (2017 - 2026) Analysis & Trends
Arcus Biosciences' EPS (Basic) history runs 10 years deep, the most recent figure standing at -$1.02 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 10.32% year-over-year to -$1.02; the TTM figure through Mar 2026 stood at -$2.94 (up 25.95% YoY), while the FY2025 annual figure was -$3.29, down 4.64% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$1.02, down from -$0.99 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.05 in Q1 2024, with the low at -$1.27 in Q3 2025.
- The 5-year median for EPS (Basic) is -$1.01 (2024), against an average of -$0.96.
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) soared 95.77% in 2024, then sank 2352.85% in 2025.
- Arcus Biosciences' EPS (Basic) stood at -$0.93 in 2022, then retreated by 17.63% to -$1.09 in 2023, then gained by 4.69% to -$1.04 in 2024, then increased by 5.4% to -$0.99 in 2025, then dropped by 3.42% to -$1.02 in 2026.
- Business Quant data shows RCUS's EPS (Basic) at -$1.02 in Q1 2026, -$0.99 in Q4 2025, and -$1.27 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Arcus Biosciences | 3.74 Bn | 3.04 Bn | - | -0.72 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.72 |
| Mar 31, 2026 | -1.02 |
| Dec 31, 2025 | -0.99 |
| Sep 30, 2025 | -1.27 |
| Mar 31, 2025 | -1.14 |
| Dec 31, 2024 | -1.04 |
| Sep 30, 2024 | -1.01 |
| Jun 30, 2024 | -1.02 |
| Mar 31, 2024 | -0.05 |
| Dec 31, 2023 | -1.09 |
| Sep 30, 2023 | -0.95 |
| Jun 30, 2023 | -1.02 |
| Mar 31, 2023 | -1.10 |
| Dec 31, 2022 | -0.93 |
| Sep 30, 2022 | -0.90 |
| Jun 30, 2022 | -0.93 |
| Mar 31, 2022 | -0.96 |
| Dec 31, 2021 | 4.03 |
| Sep 30, 2021 | -1.09 |
| Jun 30, 2021 | -1.07 |